The Oncology Nutrition Market is expected to register a CAGR of 8.9% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Oncology Nutrition Market report covers analysis by Cancer type (Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Lung Cancer, Breast Cancer, Blood Cancer, Other Cancers), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Oncology Nutrition Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Oncology Nutrition Market Segmentation
Cancer type- Head and Neck Cancers
- Stomach and Gastrointestinal Cancers
- Lung Cancer
- Breast Cancer
- Blood Cancer
- Other Cancers
Strategic Insights
Oncology Nutrition Market Growth Drivers- Increasing incidence of cancer: An increasing incidence of cancer worldwide is one of the major drivers of the market for oncology nutrition. Cancer patients often suffer from malnutrition due to the disease itself and the effects of chemotherapy and radiation, which cause loss of appetite, nausea, and metabolic changes. The growing need for compensating these nutritional deficiencies with specialized nutritional products that aid in their health and well-being as they undergo treatment is boosting the need for such products.
- Increasing awareness about Nutrition in Cancer Care: Healthcare professionals and patients alike are increasingly becoming aware of the importance of nutrition in cancer care. Proper nutritional support can enhance the effectiveness of cancer treatments, improve recovery times, and enhance the quality of life for patients. Such awareness is increasingly leading to the adoption of oncology-specific nutritional products and services, which contributes to market growth.
- Advances in personalized nutrition: Nutritional support has also started trending towards more individualized plans based on individual needs, preferences, and regimens. For example, some clinics offer nutrition tailored to individual needs in oncology. Personalized nutrition plans according to individual needs and treatment regimens have gained increased interest. Thus, specific deficiencies could be handled while the plan overall supports treatment.
- Development of innovative nutritional products: The oncology nutrition market is experiencing innovative products to address the special needs of cancer patients. Such products include high-protein supplements, immune-boosting formulas, and nutritionally complete meal replacements. Formulation technologies are being improved to develop products that are more palatable, easier to digest, and better suited to manage the side effects of cancer treatment, enhancing patient compliance and outcomes.
- Increasing use of enteral nutrition: Enteral nutrition by feeding tubes inserted directly into the stomach or small intestine is increasingly common in the care of cancer patients, especially those unable to meet all their nutritional needs by oral intake. The trend and demand for specialized formulas are increasing with enteral nutrition as they meet the metabolic needs of a cancer patient and can also help maintain nutritional status during treatment.
- Nutrition services integration into cancer care plans: This includes the integration of nutrition services in comprehensive care plans by hospitals and cancer treatment centers. Here, dietitians and nutritionists have become a vital part of oncology care teams, and this ensures the provision of customized dietary advice as well as monitoring the patient's nutritional status throughout treatment. Thus, these measures have brought improvement in the outcomes of patients, leading to growth in oncology nutrition products.
- Immunonutrition research and developments: Immunonutrition is focused on advancing the human immune response using specific nutrients. This area of interest is booming in oncology, and nutritional support products that increase immune function can not only help patients with cancer endure the treatment process with greater ease but also minimize the risk of infection during treatment. Development and progression in this area are expected to release new products into the market and, as such, shall lead to new avenues of revenue through the oncology nutrition market.
- Health Care Provider Collaboration: Co-development between nutritional product manufacturers and healthcare providers is opening new opportunities for nutritional solutions that can be targeted and designed. Collaborations with oncologists, dietitians, and cancer care centers can assist companies in making their products align better with clinical needs, which can offer easier access to the patient population, thus allowing deeper market penetration
- Integration of Digital Health and Telemedicine: Digital health technologies, like telemedicine platforms and mobile applications, are also opening new opportunities for the oncology nutrition market. These digital health technologies provide remote nutritional counseling, dietary monitoring, and customized nutrition plans for patients, hence making it possible for them to access nutritional support from anywhere. This trend will likely expand the reach of oncology nutrition services and products.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Oncology Nutrition Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Oncology Nutrition Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?

Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Oncology Nutrition Market are Increasing incidence of cancer, Increasing awareness about Nutrition in Cancer Care, and Advances in personalized nutrition
The key future trends of the market are Development of innovative nutritional products, Increasing use of enteral nutrition, and Nutrition services integration into cancer care plans
The leading players operating in the Oncology Nutrition Market include Abbott, Nestle S.A., Nutricia, Fresenius Kabi India Pvt. Ltd, B. Braun Melsungen AG, Mead Johnson Nutrition Company, Hormel Foods Corporation, Meiji Holdings Co., Ltd., Victus, Inc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oncology Nutrition Market - By Cancer type
1.3.2 Oncology Nutrition Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ONCOLOGY NUTRITION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. ONCOLOGY NUTRITION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ONCOLOGY NUTRITION MARKET - GLOBAL MARKET ANALYSIS
6.1. ONCOLOGY NUTRITION - GLOBAL MARKET OVERVIEW
6.2. ONCOLOGY NUTRITION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ONCOLOGY NUTRITION MARKET - REVENUE AND FORECASTS TO 2028 - CANCER TYPE
7.1. OVERVIEW
7.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
7.3. HEAD AND NECK CANCERS
7.3.1. Overview
7.3.2. Head and Neck Cancers Market Forecast and Analysis
7.4. STOMACH AND GASTROINTESTINAL CANCERS
7.4.1. Overview
7.4.2. Stomach and Gastrointestinal Cancers Market Forecast and Analysis
7.5. LUNG CANCER
7.5.1. Overview
7.5.2. Lung Cancer Market Forecast and Analysis
7.6. BREAST CANCER
7.6.1. Overview
7.6.2. Breast Cancer Market Forecast and Analysis
7.7. BLOOD CANCER
7.7.1. Overview
7.7.2. Blood Cancer Market Forecast and Analysis
7.8. OTHER CANCERS
7.8.1. Overview
7.8.2. Other Cancers Market Forecast and Analysis
8. ONCOLOGY NUTRITION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Oncology Nutrition Market Overview
8.1.2 North America Oncology Nutrition Market Forecasts and Analysis
8.1.3 North America Oncology Nutrition Market Forecasts and Analysis - By Cancer type
8.1.4 North America Oncology Nutrition Market Forecasts and Analysis - By Countries
8.1.4.1 United States Oncology Nutrition Market
8.1.4.1.1 United States Oncology Nutrition Market by Cancer type
8.1.4.2 Canada Oncology Nutrition Market
8.1.4.2.1 Canada Oncology Nutrition Market by Cancer type
8.1.4.3 Mexico Oncology Nutrition Market
8.1.4.3.1 Mexico Oncology Nutrition Market by Cancer type
8.2. EUROPE
8.2.1 Europe Oncology Nutrition Market Overview
8.2.2 Europe Oncology Nutrition Market Forecasts and Analysis
8.2.3 Europe Oncology Nutrition Market Forecasts and Analysis - By Cancer type
8.2.4 Europe Oncology Nutrition Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Oncology Nutrition Market
8.2.4.1.1 Germany Oncology Nutrition Market by Cancer type
8.2.4.2 France Oncology Nutrition Market
8.2.4.2.1 France Oncology Nutrition Market by Cancer type
8.2.4.3 Italy Oncology Nutrition Market
8.2.4.3.1 Italy Oncology Nutrition Market by Cancer type
8.2.4.4 Spain Oncology Nutrition Market
8.2.4.4.1 Spain Oncology Nutrition Market by Cancer type
8.2.4.5 United Kingdom Oncology Nutrition Market
8.2.4.5.1 United Kingdom Oncology Nutrition Market by Cancer type
8.2.4.6 Rest of Europe Oncology Nutrition Market
8.2.4.6.1 Rest of Europe Oncology Nutrition Market by Cancer type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Oncology Nutrition Market Overview
8.3.2 Asia-Pacific Oncology Nutrition Market Forecasts and Analysis
8.3.3 Asia-Pacific Oncology Nutrition Market Forecasts and Analysis - By Cancer type
8.3.4 Asia-Pacific Oncology Nutrition Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Oncology Nutrition Market
8.3.4.1.1 Australia Oncology Nutrition Market by Cancer type
8.3.4.2 China Oncology Nutrition Market
8.3.4.2.1 China Oncology Nutrition Market by Cancer type
8.3.4.3 India Oncology Nutrition Market
8.3.4.3.1 India Oncology Nutrition Market by Cancer type
8.3.4.4 Japan Oncology Nutrition Market
8.3.4.4.1 Japan Oncology Nutrition Market by Cancer type
8.3.4.5 South Korea Oncology Nutrition Market
8.3.4.5.1 South Korea Oncology Nutrition Market by Cancer type
8.3.4.6 Rest of Asia-Pacific Oncology Nutrition Market
8.3.4.6.1 Rest of Asia-Pacific Oncology Nutrition Market by Cancer type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Oncology Nutrition Market Overview
8.4.2 Middle East and Africa Oncology Nutrition Market Forecasts and Analysis
8.4.3 Middle East and Africa Oncology Nutrition Market Forecasts and Analysis - By Cancer type
8.4.4 Middle East and Africa Oncology Nutrition Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Oncology Nutrition Market
8.4.4.1.1 South Africa Oncology Nutrition Market by Cancer type
8.4.4.2 Saudi Arabia Oncology Nutrition Market
8.4.4.2.1 Saudi Arabia Oncology Nutrition Market by Cancer type
8.4.4.3 U.A.E Oncology Nutrition Market
8.4.4.3.1 U.A.E Oncology Nutrition Market by Cancer type
8.4.4.4 Rest of Middle East and Africa Oncology Nutrition Market
8.4.4.4.1 Rest of Middle East and Africa Oncology Nutrition Market by Cancer type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Oncology Nutrition Market Overview
8.5.2 South and Central America Oncology Nutrition Market Forecasts and Analysis
8.5.3 South and Central America Oncology Nutrition Market Forecasts and Analysis - By Cancer type
8.5.4 South and Central America Oncology Nutrition Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Oncology Nutrition Market
8.5.4.1.1 Brazil Oncology Nutrition Market by Cancer type
8.5.4.2 Argentina Oncology Nutrition Market
8.5.4.2.1 Argentina Oncology Nutrition Market by Cancer type
8.5.4.3 Rest of South and Central America Oncology Nutrition Market
8.5.4.3.1 Rest of South and Central America Oncology Nutrition Market by Cancer type
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. ONCOLOGY NUTRITION MARKET, KEY COMPANY PROFILES
10.1. ABBOTT
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. NESTLE S.A.
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. NUTRICIA
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. FRESENIUS KABI INDIA PVT. LTD
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. B. BRAUN MELSUNGEN AG
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. MEAD JOHNSON NUTRITION COMPANY
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. HORMEL FOODS CORPORATION
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. MEIJI HOLDINGS CO., LTD.
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. VICTUS, INC
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. GLOBAL HEALTH PRODUCTS, INC.
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
1. Abbott
2. Nestle S.A.
3. Nutricia
4. Fresenius Kabi India Pvt. Ltd
5. B. Braun Melsungen AG
6. Mead Johnson Nutrition Company
7. Hormel Foods Corporation
8. Meiji Holdings Co., Ltd.
9. Victus, Inc
10. Global Health Products, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.